FDA Inspection
Biomat USA, Inc.Biomat USA, Inc. – FDA Inspection, Apr 8, 2010
Record Details
This FDA Inspection record concerns Biomat USA, Inc., with an inspection on April 8, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA, Inc.
- Inspection Date
- April 8, 2010
- Product Type
- Biologics
View Company Profile
ID · e0617a4e-9970-4425-aa2e-65b475098623
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 658222
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Biomat USA, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 24, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 9, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 26, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 19, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA, Inc.
- FDA Inspection 1063917 - 2018-07-24
- FDA Inspection 984810 - 2016-09-09
- FDA Inspection 898284 - 2014-09-26
- FDA Inspection 800555 - 2012-09-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.